Lenz Therapeutics announced it raised $83.5 Million in an initial filing from an offering of $83.5 Million

Mar 10, 2023•almost 3 years ago

Amount Raised

$83.5 Million

San DiegoTherapeuticsBiotechnology

Company Information

Company

Lenz Therapeutics

Location

445 MARINE VIEW AVE., SUITE #320

San Diego, California, United States

About

Graphite Bio, Inc. (previously trading on Nasdaq under the ticker symbol “GRPH”) focused on biopharmaceuticals. It has merged with LENZ Therapeutics, Inc. to form a new combined company.

Related People

7 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Lenz Therapeutics announced it raised $83.5 Million in an initial filing from an offering of $83.5 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information